Osteoporosis
Parathyroid hormone anabolic effect is not abrogated by neurofibromatosis haploinsufficiency
Published in Gene Therapy Weekly, May 18th, 2006
"Approximately 50% of NF1 patients exhibit skeletal pathology, such as premature osteoporosis or pseudoarthroses. Loss of neurofibromin deregulates Ras signal transduction to affect generation of mitogen-activated protein kinase and Akt, both of which have been implicated in parathyroid hormone (PTH) anabolic mechanisms," wrote X. Yu and colleagues, Indiana University.
They continued, "Our aim was to determine if loss of neurofibromin impaired the anabolic effect of PTH on bone mass. Nf1...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-05-18)
More Articles from Gene Therapy Weekly
- Bloom Syndrome
Bloom syndrome gene expression silenced in human cells by gene targeting - Diabetes Gene Therapy
Type 1 diabetes genetic susceptibility is demonstrated by in vivo RNA interference - Epstein-Barr Virus
EBV antigens are re-targeted by T cells following TCR gene transfer - Gene Research
Mouse study reveals human gene therapy may pose substantial cancer risk - Neuroscience
Learning is impaired by NMDAR1 subunit knock-down in hippocampal neurons - Accreditation
CombiMatrix Molecular Diagnostics receives accreditation from CAP - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
